NYSE: NMRNomura Holdings Inc Stock
$3.80+0.04 (+1.06%)
Updated Mar 31, 2023
NMR Price
$3.80
Fair Value Price
N/A
Market Cap
$11.47B
52 Week Low
$3.00
52 Week High
$4.30
P/E
11.08x
P/B
0.54x
P/S
1.16x
PEG
N/A
Dividend Yield
N/A
Revenue
$10.01B
Earnings
$1.17B
Gross Margin
92.3%
Operating Margin
16.36%
Profit Margin
10.5%
Debt to Equity
13.88
Operating Cash Flow
-$11B
Beta
0.79
Next Earnings
Apr 26, 2023
Ex-Dividend
N/A
Next Dividend
N/A
NMR Overview
Nomura Holdings, Inc. offers securities, investment and other financial sevices to individuals, corporations, financial institutions, and governments. Its Sales segment provides investment consultation services to individual clients in Japan. The Asset Management segment offers development and management of investment trusts and investment advisory services. The Wholesale segment sells and trade bonds, equity securities, derivatives and foreign exchange. Nomura Holdings was incorporated in 1925 and is headquartered in Tokyo, Japan.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NMR scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
NMR was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NMR is good value based on its earnings relative to its share price (11.08x), compared to the US market average (22.13x)
P/E vs Market Valuation
NMR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more NMR due diligence checks available for Premium users.
Be the first to know about important NMR news, forecast changes, insider trades & much more!
NMR News
Valuation
NMR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
11.08x
Industry
16.27x
Market
22.13x
NMR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
NMR is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
NMR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.54x
Industry
1.57x
NMR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
NMR's financial health
Profit margin
Revenue
$11.2B
Net Income
$1.2B
Profit Margin
10.5%
NMR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$356.1B
Liabilities
$331.7B
Debt to equity
13.88
NMR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NMR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$11.2B
Investing
-$371.6M
Financing
$8.8B
NMR vs Capital Market Stocks
Nomura Holdings Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.